Promoting HPV Vaccination among Young Adults in Texas

在德克萨斯州的年轻人中推广 HPV 疫苗接种

基本信息

  • 批准号:
    10411983
  • 负责人:
  • 金额:
    $ 65.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-01 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

Project summary Human papillomavirus (HPV) vaccine is important because it protects against cancers caused by HPV infection. Nearly 79 million people are currently infected in the United States and about 14 million people become infected with HPV each year. HPV infection can cause cancers in both women and men and the financial burdens of these HPV-related diseases cost more than $8 billion per year in the US. The most recently approved HPV vaccination can prevent up to 74% of HPV-associated invasive cancers. Thus, HPV vaccination is one of the most profound opportunities in cancer prevention today. The Centers for Disease Control and Prevention (CDC) recommends HPV vaccines through age 26. Among adults18–26 years, HPV vaccination completion is unacceptably low whereas HPV infection rates are unacceptably high. There is also a lack of interventions to improve HPV vaccination rates among young adults who were not vaccinated during childhood. In the area of HPV vaccination uptake, males have disproportionately low rates and minorities have lower rates of completing the vaccinations compared to non-Hispanic whites. This study aims to fill in the important gaps by using a 2 by 3 factorial design to test the independent and combined effects of a multilevel intervention: school-based HPV vaccine administration (no access vs. access) at the system level and web- based narratives (no access vs. video vs. written) at the individual level. This intervention is developed based on pilot studies and socio-ecological models that recognize the impact multiple levels of influence have on behaviors. The 2 by 3 factorial design results in six groups: ) standard CDC information about HPV vaccination (control); 2) video narratives about HPV vaccination; 3) written narratives about HPV vaccination; 4) access to HPV vaccine at school combined with standard CDC information, 5) access to HPV vaccine at school combined with video narratives, or 6) access to HPV vaccine at school combined with written narratives . This design allows us to investigate the independent and combined effects of tailored narratives and school-based vaccine access on HPV vaccination. College students aged 18- 26 who are not previously vaccinated against HPV will be randomly assigned to one of the six groups. Primary outcomes are HPV vaccine initiation and completion at 3- and 9-month follow-ups, respectively. This study has implications for creating a new paradigm in HPV vaccination by inspiring future new research directions that include multiple levels of influence to improve HPV vaccinations. This study will make a significant positive impact on public health, as it is using evidence-based strategies tailored for young adults aged 18-26 years to promote “catch up” HPV vaccination. If successful, the web-based intervention can be easily disseminated because it is brief and scalable. School-based HPV vaccinations can be implemented on college campuses in the future to improve healthcare delivery. Success and lessons learned in this study will inform future strategies to develop tailored narrative messages for different social groups.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Qian Lu其他文献

Qian Lu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Qian Lu', 18)}}的其他基金

Developmental Core
发展核心
  • 批准号:
    10661206
  • 财政年份:
    2023
  • 资助金额:
    $ 65.88万
  • 项目类别:
Promoting HPV Vaccination among Young Adults in Texas
在德克萨斯州的年轻人中推广 HPV 疫苗接种
  • 批准号:
    10218874
  • 财政年份:
    2021
  • 资助金额:
    $ 65.88万
  • 项目类别:
Promoting HPV Vaccination among Young Adults in Texas
在德克萨斯州的年轻人中推广 HPV 疫苗接种
  • 批准号:
    10683076
  • 财政年份:
    2021
  • 资助金额:
    $ 65.88万
  • 项目类别:
Writing to Heal: A Culturally Based Brief Expressive Writing Intervention for Chinese Immigrant Breast Cancer Survivors
写作治愈:针对中国移民乳腺癌幸存者的基于文化的简短表达性写作干预
  • 批准号:
    10375527
  • 财政年份:
    2021
  • 资助金额:
    $ 65.88万
  • 项目类别:
Writing to Heal: A Culturally Based Brief Expressive Writing Intervention for Chinese Immigrant Breast Cancer Survivors
写作治愈:针对中国移民乳腺癌幸存者的基于文化的简短表达性写作干预
  • 批准号:
    10675433
  • 财政年份:
    2021
  • 资助金额:
    $ 65.88万
  • 项目类别:
Joy Luck Academy: A Culturally Sensitive Social Support Intervention
喜福学院:文化敏感的社会支持干预
  • 批准号:
    8761926
  • 财政年份:
    2014
  • 资助金额:
    $ 65.88万
  • 项目类别:
Joy Luck Academy: A Culturally Sensitive Social Support Intervention
喜福学院:文化敏感的社会支持干预
  • 批准号:
    8919304
  • 财政年份:
    2014
  • 资助金额:
    $ 65.88万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 65.88万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.88万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 65.88万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.88万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 65.88万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.88万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 65.88万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 65.88万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 65.88万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了